Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all ...

How would you summarize your study for a lay audience? T helper (TH) cells are essential immune cells that help other immune ...

Vijay K. Kuchroo, PhD, DVM, of the Gene Lay Institute of Immunology and Inflammation of Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School and the Ann Romney ...

Multiple Myeloma, a cancer of the plasma cells in the bone marrow, is the third most common blood cancer in Europe. Despite recent advanced in treatment that has increased survival, it is still an ...

LOUISVILLE, Ky. -- A CD70-targeted CAR T-cell therapy for advanced kidney cancer continued to show durable activity in ...

T helper (TH) cells are essential immune cells that help other immune cells function effectively. When activated in response to environmental stimuli, these cells can differentiate into either TH1 ...

UCSF researchers develop customizable SNIPR sensors that activate engineered cells only near tumors, promising precise cancer ...

During a Case-Based Roundtable® event, Saad Z. Usmani, MD, FACP, MBA, discussed quality of life and the future with CAR ...

A clinical trial showed CAR-T cell therapy may shrink aggressive brain and spinal cord tumours in young patients. View on ...

By virtue of surviving the immune system and the immune response within a patient, solid tumors have figured out ways to ...